Paysign (NASDAQ:PAYS) Shares Down 5.4% – What’s Next?

Shares of Paysign, Inc. (NASDAQ:PAYS) traded down 5.4% on Monday. The company traded as low as $14.25 and last traded at $13.90. Approximately 451,324 shares changed hands during trading, a decline of 38% from the average session volume of 729,734 shares. The stock had previously closed at $14.69.

Key Headlines Impacting Paysign

Investors following PAYS have been watching these headlines:

• Positive Sentiment: Q3 revenue rose 42.6% year over year to a record $30.8 million, beating estimates, while EPS of $0.11 topped the $0.09 consensus. The operating margin more than tripled to 23.8%; pharma revenue grew 109.8%. Paysign Q3 2026 results
• Positive Sentiment: DA Davidson lowered its price target to $14 from $15 but maintained a Buy rating, indicating the firm still sees upside. DA Davidson recommendations
• Negative Sentiment: FY 2026 EPS guidance of $0.37–$0.38 came in well below the $0.51 consensus. Revenue guidance of $114–$117 million spans the $114.7 million consensus, but investors may focus on the earnings shortfall. Paysign 2026 outlook

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Lake Street Capital boosted their target price on shares of Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a report on Tuesday, September 15th. Maxim Group downgraded shares of Paysign from a “buy” rating to a “hold” rating in a research report on Wednesday. Weiss Ratings upgraded shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. DA Davidson reduced their price objective on shares of Paysign from $15.00 to $14.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Barrington Research set a $15.00 price target on shares of Paysign in a report on Tuesday, August 11th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $14.67.

Paysign Trading Down 6.3%

The stock has a market capitalization of $536.67 million, a PE ratio of 29.11 and a beta of 0.92. The company’s 50-day moving average is $13.82 and its 200 day moving average is $8.63.

Paysign (NASDAQ:PAYS) last released its earnings results on Monday, November 9th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The company had revenue of $30.80 million during the quarter, compared to analysts’ expectations of $29.02 million. Paysign had a net margin of 18.48% and a return on equity of 37.20%. Sell-side analysts forecast that Paysign, Inc. will post 0.58 EPS for the current fiscal year.

Insider Transactions at Paysign

In related news, insider Michael C. Ngo sold 79,925 shares of the company’s stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $12.74, for a total value of $1,018,244.50. Following the transaction, the insider directly owned 2,350,000 shares of the company’s stock, valued at $29,939,000. This represents a 3.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Mark Newcomer sold 50,000 shares of the firm’s stock in a transaction on Friday, October 9th. The stock was sold at an average price of $15.34, for a total value of $767,000.00. Following the completion of the transaction, the chief executive officer owned 9,113,002 shares of the company’s stock, valued at $139,793,450.68. This trade represents a 0.55% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 259,904 shares of company stock worth $3,402,424. Company insiders own 24.50% of the company’s stock.

Institutional Investors Weigh In On Paysign

Institutional investors and hedge funds have recently modified their holdings of the company. Legal & General Group Plc acquired a new position in Paysign in the 2nd quarter worth approximately $35,000. D.A. Davidson & CO. lifted its stake in Paysign by 38.4% during the 3rd quarter. D.A. Davidson & CO. now owns 18,323 shares of the company’s stock valued at $247,000 after acquiring an additional 5,082 shares during the period. Allspring Global Investments Holdings LLC boosted its holdings in shares of Paysign by 11.4% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 65,853 shares of the company’s stock valued at $389,000 after acquiring an additional 6,717 shares during the last quarter. EFG International AG purchased a new stake in shares of Paysign in the 2nd quarter valued at $68,000. Finally, Quantbot Technologies LP purchased a new stake in shares of Paysign in the 2nd quarter valued at $97,000. Institutional investors and hedge funds own 25.89% of the company’s stock.

About Paysign

Paysign, Inc. provides prepaid card programs, payment processing and related financial technology services. Its platform supports organizations that need to distribute funds and manage payments, including businesses in the healthcare sector. The company serves plasma collection centers with donor compensation and payment solutions, and works with pharmaceutical companies on patient assistance and affordability programs. Its services also support payments for clinical trials and other disbursement needs.